Published in Am J Hematol on July 01, 2000
Introducing case management to a general medicine ward team of a teaching hospital. Acad Med (1997) 0.94
Endurance swimming, intravascular hemolysis, anemia, and iron depletion. New perspective on athlete's anemia. Am J Med (1986) 0.87
High-dose combination alkylating agent therapy with autologous bone marrow rescue for refractory solid tumors. J Clin Oncol (1988) 0.84
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease. J Infect (2000) 0.82
Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes. Bone Marrow Transplant (2004) 0.77
Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation. Anticancer Drugs (2000) 0.77
Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining. Clin Lab Haematol (2006) 0.75
Autologous bone marrow transplantation for non-Hodgkin lymphoma. J Okla State Med Assoc (1994) 0.75
High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study. Bone Marrow Transplant (1995) 0.75
Autologous bone marrow transplantation for metastatic breast cancer. J Okla State Med Assoc (1994) 0.75
Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Am J Hematol (1996) 0.75
Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma. South Med J (1995) 0.75
G-CSF-mobilized donor leukocyte infusions as immunotherapy in acute leukemia relapsing after allogeneic marrow transplantation. J Hematother (1998) 0.75
The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML. Biol Blood Marrow Transplant (2001) 0.75
Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results. J Okla State Med Assoc (1998) 0.75
Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors. Bone Marrow Transplant (1998) 0.75
Formation of fibrin clots in cryopreserved stem cell bags during thawing procedure: lack of impact on engraftment in autologous stem cell transplantation. Bone Marrow Transplant (1999) 0.75